Lib is one of those Nplate® patients with her own story to share. Watch Lib’s story below.
—Lib, chronic ITP patient on Nplate®
Watch three patients communicate with their doctor about ITP treatment options in these sample conversations. You will also hear some tips from an ITP expert about having productive conversations with your doctor.
Even though I was diagnosed with something I thought was scary …
I kept a positive mind and outlook. —Debra, chronic ITP patient on Nplate®
It took quite some time for me to receive a chronic ITP diagnosis. It was quite baffling for the medical team to determine exactly what was wrong with me. I didn’t understand much at the time I was in the intensive care unit. I didn’t understand why I kept receiving platelet transfusions, yet my platelet levels never went up. The doctors were trying to figure this out as well. At the time, all I really understood was that my platelets were extremely low.
More than 70,000 people worldwide have been treated with Nplate® over the last 10 years
Although I wish I never had ITP, I am grateful for all the support I have had on this journey. —Kristen, chronic ITP patient on Nplate®
I was diagnosed with chronic ITP in the winter of 2010. Even though I had never heard of this condition and wanted to find out more, I initially avoided the Internet. I knew that the Internet can be full of misinformation when it comes to medical problems.
We tried several treatments, including steroids and intravenous immunoglobulin (IVIG). None of the treatments were effective in helping me achieve my treatment goal, so my hematologist recommended a splenectomy. This concerned me, so I decided to research what other options were available to me. I finally turned to the Internet while searching for answers and came across the Platelet Disorder Support Association (PDSA). I particularly liked the firsthand experiences of others with ITP that I could read about on the discussion boards.
Learn how Nplate® has been helping people with ITP for more than a decade
Important Safety Information
What is the most important information I should know about Nplate®?
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.
Higher risk for blood clots:
What are the possible side effects of Nplate®?
How will I receive Nplate®?
Nplate® is given as an injection under the skin (subcutaneous) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.
APPROVED USES
Nplate® is a prescription medicine used to treat low blood platelet counts (thrombocytopenia) in:
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS), or low platelet count caused by any condition other than immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.
Please see Prescribing Information and Medication Guide for more information about Nplate® on Nplate.com.
References
1. TK Drem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Important Safety Information
What is the most important information I should know about Nplate®?
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.
Higher risk for blood clots: